Your session is about to expire
← Back to Search
Behavioural Intervention
Cranial Electrotherapy Stimulation for Anxiety
N/A
Recruiting
Led By Kana Okano, Ph.D.
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Can sit and stand freely
18-40 years of age (17-40 if emancipated minor)
Must not have
Use of prescription medications, other than oral contraceptives
History of a neurological or psychological disorder (such as depression, anxiety disorders, migraines, cluster headaches, seizures, Post-traumatic stress disorder (PTSD) or panic attacks)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, at each of the 20 ces sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last ces
Summary
This trial studies how 20 sessions of Cranial Electrotherapy Stimulation (CES) affects Soldiers' biochemical, physiological, emotional and behavioral responses to stress.
Who is the study for?
This trial is for individuals aged 18-40 who have never used Cranial Electrotherapy Stimulation (CES) and can sit and stand freely. They must be willing to have their data stored for future research. People with hypertension, insomnia, brain conditions, pregnancy plans during the study, history of brain injury or illness, use of certain medications (excluding oral contraceptives), nursing mothers, or those with neurological/psychological disorders are excluded.
What is being tested?
The study tests how 20 sessions of CES affect soldiers' stress responses by measuring biochemical markers like salivary alpha amylase and cortisol, physiological indicators such as heart rate variability, emotional state anxiety levels, and cognitive task performance before and after the treatment compared to a Sham CES group.
What are the potential side effects?
While specific side effects are not detailed in this summary information provided about the clinical trial on CES for acute stress response in Soldiers; generally speaking CES may cause mild headaches or skin irritation at electrode sites.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can sit and stand without help.
Select...
I am between 18 and 40 years old, or 17 and emancipated.
Select...
I have never used or been treated with CES.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking prescription medications other than birth control pills.
Select...
I have a history of neurological or psychological disorders.
Select...
I have a history of heart disease or irregular heartbeats.
Select...
I have had an illness that caused brain injury.
Select...
I have had a brain-related condition in the past.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, at each of the 20 ces sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last ces
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, at each of the 20 ces sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last ces
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline in decision making accuracy
Change from baseline in decision making reaction time
Change from baseline in heart rate during stressful lethal force decision making task
+7 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active CESActive Control1 Intervention
Active Cranial Electrotherapy Stimulation (CES)
Group II: Sham CESPlacebo Group1 Intervention
Sham Cranial Electrotherapy Stimulation (CES)
Find a Location
Who is running the clinical trial?
Tufts UniversityLead Sponsor
270 Previous Clinical Trials
594,691 Total Patients Enrolled
1 Trials studying Anxiety
124 Patients Enrolled for Anxiety
United States Department of DefenseFED
917 Previous Clinical Trials
334,499 Total Patients Enrolled
7 Trials studying Anxiety
1,106 Patients Enrolled for Anxiety
Kana Okano, Ph.D.Principal InvestigatorTufts University